87 related articles for article (PubMed ID: 9041157)
1. A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fraction.
Kaleli S; Kösebay D; Beşe T; Demirkiran F; Oz UA; Arvas M; Aydinli K; Erkün E
Cancer; 1997 Mar; 79(5):944-51. PubMed ID: 9041157
[TBL] [Abstract][Full Text] [Related]
2. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
Xue F; Jiao S; Zhao F
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
[TBL] [Abstract][Full Text] [Related]
4. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
[TBL] [Abstract][Full Text] [Related]
6. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
7. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
[TBL] [Abstract][Full Text] [Related]
11. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
Lindahl B; Willén R
Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer.
Santala M; Talvensaari-Mattila A; Kauppila A
Anticancer Res; 2003; 23(3C):3097-103. PubMed ID: 12926169
[TBL] [Abstract][Full Text] [Related]
17. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
18. Role of flow cytometric DNA analysis in the prognosis of endometrial carcinoma.
Mangili F; De Marzi P; Di Rocco M; Panacci N; Sassi I
Eur J Histochem; 1997; 41 Suppl 2():135-6. PubMed ID: 9859818
[No Abstract] [Full Text] [Related]
19. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
Michels JJ; Marnay J; Plancoulaine B; Chasle J
Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
[TBL] [Abstract][Full Text] [Related]
20. Prognostic index models in stage I and II endometrial carcinoma.
Nordström B; Bergström R; Strang P
Anticancer Res; 1998; 18(5B):3717-24. PubMed ID: 9854483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
